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Moving beyond size: vorticity and energy
loss are correlated with right ventricular
dysfunction and exercise intolerance in repaired
Tetralogy of Fallot
Yue‑Hin Loke1* , Francesco Capuano2, Vincent Cleveland3, Jason G. Mandell1, Elias Balaras4 and
Laura J. Olivieri1,3

Abstract
Background: The global effect of chronic pulmonary regurgitation (PR) on right ventricular (RV) dilation and dys‑
function in repaired Tetralogy of Fallot (rTOF) patients is well studied by cardiovascular magnetic resonance (CMR).
However, the links between PR in the RV outflow tract (RVOT), RV dysfunction and exercise intolerance are not clari‑
fied by conventional measurements. Not all patients with RV dilation share the same intracardiac flow characteristics,
now measurable by time resolved three-dimensional phase contrast imaging (4D flow). In our study, we quantified
regional vorticity and energy loss in rTOF patients and correlated these parameters with RV dysfunction and exercise
capacity.
Methods: rTOF patients with 4D flow datasets were retrospectively analyzed, including those with transannular/
infundibular repair and conduit repair. Normal controls and RV dilation patients with atrial-level shunts (Qp:Qs > 1.2:1)
were included for comparison. 4D flow was post-processed using IT Flow (Cardioflow, Japan). Systolic/diastolic vorti‑
city (ω, 1/s) and viscous energy loss (VEL, mW) in the RVOT and RV inflow were measured. To characterize the rela‑
tive influence of diastolic vorticity in the two regions, an RV Diastolic Vorticity Quotient (ωRVOT-Diastole/ωRV Inflow-Diastole,
RV-DVQ) was calculated. Additionally, RVOT Vorticity Quotient (ωRVOT-Diastole/ωRVOT-Systole, RVOT-VQ) and RVOT Energy
Quotient ( VELRVOT-Diastole/VELRVOT-Systole, RVOT-EQ) was calculated. In rTOF, measurements were correlated against con‑
ventional CMR and exercise stress test results.
Results: 58 rTOF patients, 28 RV dilation patients and 12 controls were included. RV-DVQ, RVOT-VQ, and RVOT-EQ
were highest in rTOF patients with severe PR compared to rTOF patients with non-severe PR, RV dilation and con‑
trols (p < 0.001). RV-DVQ positively correlated with RV end-diastolic volume (0.683, p < 0.001), PR fraction (0.774,
p < 0.001) and negatively with RV ejection fraction (− 0.521, p = 0.003). Both RVOT-VQ, RVOT-EQ negatively correlated
with VO2-max (− 0.587, p = 0.008 and − 0.617, p = 0.005) and % predicted VO2-max (− 0.678, p = 0.016 and − 0.690,
p = 0.001).
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Conclusions: In rTOF patients, vorticity and energy loss dominate the RVOT compared to tricuspid inflow, correlating
with RV dysfunction and exercise intolerance. These 4D flow-based measurements may be sensitive biomarkers to
guide surgical management of rTOF patients.
Keywords: Tetralogy of Fallot, Intracardiac flow, Vorticity, 4D flow

Background
In repaired Tetralogy of Fallot (rTOF) patients, the longterm consequences of chronic pulmonary regurgitation
(PR) on right ventricular (RV) dilation, RV dysfunction,
ventricular arrhythmias and mortality have been wellstudied [1]. Thus, measurements of RV size and function as guided by cardiovascular magnetic resonance
(CMR) have provided critical interventional thresholds
for pulmonary valve replacement (PVR) [2, 3]. However,
current guidelines acknowledge the limitations of these
conventional CMR measurements [2, 3], as they do not
necessarily predict deterioration of the RV [4], nor do
they incorporate the diversity of RV morphology, RV
motion, and RV outflow tract (RVOT) geometry [5–7].
Exclusive interpretation of the RV in rTOF using indexed
RV end-diastolic volume (RVEDVI), indexed RV endsystolic volume (RVESVI), RV ejection fraction (RVEF)
and pulmonary regurgitant fraction (PR%) does not fully
describe RV dysfunction, nor correlate with exercise
intolerance [8–11]. Furthermore, the direct link between
PR, RV dysfunction and exercise intolerance has not been
clarified, as the resultant intracardiac flow abnormalities
from PR have not been comprehensively studied in rTOF
patients.
Recent advances in CMR now allow for time-resolved
three-dimensional phase contrast imaging (4D flow)
of intracardiac flow phenomena. With 4D flow, it is
observed that intracardiac flow parameters such as vorticity (the local spinning motion of blood) and kinetic
energy are altered in rTOF patients [12–15]. Intracardiac
flow parameters are thus promising hemodynamic biomarkers to potentially detect RV dysfunction, although
these studies have mainly correlated 4D flow biomarkers
with PR and RV dilation. These studies have also focused
on global quantification of the RV, without considering
regional abnormalities created from PR in the RVOT.
There have also not been any 4D flow studies that have
compared rTOF against other forms of chronic volume
loading in the RV.
Beyond size, dilated RVs do not all share the same intracardiac flow characteristics. Both in-vivo and in-vitro
studies have highlighted the unique pathophysiology of
rTOF patients [16–20] that are fundamentally distinct
from other forms of RV dilation. A recent echocardiographic case–control study by Moceri et al. [17] demonstrated different RV strain patterns between rTOF and

patients with atrial septal defects (ASD), despite similar
RV size. We have previously developed an in-vitro computational model of intracardiac flow in rTOF patients
using conventional CMR imaging [18–20]. Through this
computational model, we observed a pattern where the
jet of PR disrupts the natural tricuspid inflow vortex at
the RVOT, a finding also observed in an in-vitro pump
study by Mikhail et al. [16]. We conjecture that in rTOF
patients this flow phenomenon can be quantified by 4D
flow as patterns of vorticity and energy loss that are distinct from the normal RV and RV dilation patients.
Thus, in our study, we quantified regional vorticity and
energy loss in rTOF patients, and compared these values
to normal controls and RV dilation patients (those with
dilated RVs from atrial level shunts). We hypothesized
that in rTOF patients, there is distinct influence of vorticity and energy loss in the RVOT compared to normal
control and RV dilation patients, and that these intracardiac flow parameters are correlated with RV dysfunction
and exercise intolerance.

Methods
This was an Institutional Review Board-approved retrospective study involving patients who underwent a CMR
study between December 2018 and August 2020. rTOF
patients included those with pulmonary stenosis (TOFPS) or double-outlet right ventricle (DORV) variants who
underwent either transannular or infundibular patch
repair, as well as those with pulmonary atresia (TOF-PA)
who underwent RV-to-pulmonary artery (RV-PA) conduit repair. Patients with poor imaging quality or significant stent/sternal artifact were excluded. Patients with
evidence of elevated pulmonary vascular resistance (confirmed by cardiac catheterization) were also excluded. For
comparison, CMR datasets from normal controls and RV
dilation patients were included. RV dilation patients were
defined as those with ASDs or partial anomalous pulmonary venous return (PAPVR) with hemodynamically significant shunt (Qp:Qs > 1.2:1). Normal controls included
those who underwent CMR imaging for separate clinical indication (exclude cardiomyopathy, atrial shunts or
PAPVR) and found to have normal RV size, function and
pulmonary-to-systemic flow ratio (Qp:Qs) < 1.2:1.
All studies were performed with a 1.5 T CMR scanner (Siemens Healthineers, Erlangen, German). CMR
data included cine imaging (long-axis and short-axis
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cine), contrast-enhanced magnetic resonance angiography (MRA), three-dimensional (3D) steady state free
precession imaging (3D SSFP), two-dimensional phase
contrast across the pulmonary valve (Venc set between
2 and 2.5 m/s) and 4D flow. The 4D flow sequence
parameters included FOV = 280–480 × 140–230 mm,
matrix = 160 × 77, TE = 2.19 ms, TR = 37.9–59.4 ms
(dependent on number of segments per RR and RR interval; either 2 segments for RR > 750 ms or 3 segments for
RR < 750 ms), flip angle = 15, slice thickness = 1.8 mm
or 2.8 mm (dependent on patient size, either 1.8 mm for
BSA < 1.5 m2; 2.8 mm for BSA > 1.5 m2), venc = 2 m/s–
2.5 m/s and number of reconstructed phases = 20–30.
The MRA and 3D SSFP covered the entire heart with
voxel size ~ 1.4 × 1.4 × 1.4 mm. Standard clinical measurements of RVEDVI, RVESVI, RVEF, and PR% were
obtained. For rTOF patients, electrocardiogram and cardiopulmonary exercise stress test results within 1 year of
CMR study were also collated for QRS duration, V
 O2-max
and % predicted VO2-max.
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3D modeling of RVOT and RV inflow

3D end-diastolic models of the RV were first created
from MRA and 3D SSFP datasets, according to lab standard segmentation [21, 22] using commercially available
software (Mimics; Materialise, Leuven, Netherlands).
The RV was isolated between the tricuspid valve and pulmonary valve annuli. For rTOF with transannular patch,
the pulmonary valve annulus was determined by presence of either residual valve sinuses or valve tissue. The
3D models were then consistently divided into separate
components of the RV (Fig. 1), accounting for the variable geometry of the RV and RVOT: #1) A dividing plane
(parallel to 4-chamber cine plane) at the antero-septal
commissure of tricuspid annulus (most cranial aspect)
was first used to separate the RVOT and RV body; #2) the
remaining RV body was then divided half-way down the
long-axis to separate the RV inflow from RV apex. The
resulting RVOT volume is in line with corresponding RV
segments as described by Wald et al. (which also separated the RV into components) [23].

Fig. 1 The inflow and outflow components of the right ventricle (RV). Three-dimensional (3D) end-diastolic models of the RV for all three groups
were systematically performed to separate out the RV outflow tract (RVOT) and RV inflow. This was performed by Cut #1 and Cut #2 as shown in A
with corresponding landmarks. The resulting 3D models of the inflow and outflow components are shown in B
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Post‑processing of 4D flow

Each 4D flow dataset was imported into IT Flow (Cardioflow, Tokyo, Japan) [24] as separate segmentation masks
to isolate velocity flow fields within the domains of interest. After background-phase correction, the masks were
further screened to remove regions of noise artifact.
Particle tracking and vorticity mapping analysis was also
performed for qualitative assessment.
Quantification of vorticity, RVOT vorticity quotient and RV
diastolic vorticity quotient

Vorticity was quantified for each phase of the cardiac
cycle by IT Flow. Conceptually, vorticity represents the
magnitude and the axial direction of spinning. Vorticity
is defined as the curl of the velocity field:

→
−
→
ω =∇ ×−
u
Absolute vorticity (units of L/s) is calculated
→by
 spa 
tially integrating the vorticity magnitude  ω , that
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accounts for all three directions of spinning, within each
voxel:

Absolute Vorticity = ∫ �ω�dV
�
V

where V is the segmented volume of interest (e.g. RVOT
or inflow region). Since absolute vorticity is dependent on segmentation volume (units of L), the calculated
results were normalized against the volume of the segmented region as ω (units of 1/s):

ωRVOT =

Absolute VorticityRVOT
VolumeRVOT

ωRVInflow =

Absolute VorticityRVInflow
VolumeRVInflow

The peak value within the RVOT during systole
(ωRVOT-Systole), as well as the RVOT and RV inflow
during diastole (ωRVOT-Diastole, ωRV Inflow-Diastole) were

Fig. 2 Example vorticity and energy loss profiles in a repaired tetralogy of Fallot (rTOF) and right ventricular dilation (RVD) patient. For each dataset,
the peak systolic/diastolic viscous energy loss, systolic/diastolic vorticity in the RV outflow tract (RVOT) and RV inflow was selected
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measured (Fig. 2). To characterize the relative influence
of vorticity between RV inflow vs PR, and remove other
confounding effects such as heart rate and voxel size
[25], these measurements were normalized into unitless
parameters in a similar manner as PR% and echocardiographic Doppler metrics of rTOF [26, 27]. ωRVOT-Diastole/
ωRV Inflow-Diastole was calculated and represented as the
RV Diastolic Vorticity Quotient (RV-DVQ). ωRVOTDiastole/ωRVOT-Systole was also calculated and represented
as the RVOT Vorticity Quotient (RVOT-VQ).
Quantification and analysis of RVOT viscous energy loss,
RVOT energy quotient

Viscous energy loss (VEL, mW) represent viscous dissipation across the flow field within each voxel, a combined effect of blood viscosity and velocity gradient
(shear) [24]. For each direction, E is summated over
repeated indices as:



∂uj 2
1  ∂ui
µ
VEL =
+
dV
2
∂xj
∂xi
where µ is blood viscosity at 0.004 Pa·s. The peak VEL
across the RVOT in systole ( VELRVOT-Systole) and diastole
( VELRVOT-Diastole) was measured (Fig. 2). VELRVOT-Diastole/
VELRVOT-Systole was also calculated as the RVOT Energy
Quotient (RVOT-EQ).

Statistical analysis

All statistical analysis was performed with Prism 8
(Graphpad, San Diego, California, USA). One-way analysis of variance (ANOVA) was used to compare between
rTOF patients with severe PR (defined as PR% > 40%),
rTOF patients with moderate PR (PR% 20–40%), rTOF
patients with mild PR (PR% < 20%), RV dilation and control groups. Subgroup analysis of rTOF patients was also
performed: #1) rTOF patients with TOF-PS anatomy and
only infundibular or transannular patch repair (i.e. no
conduit placement) with no further surgical reintervention (i.e. no PVR), reducing any variation to RVOT geometry from a conduit hood or PVR; #2) rTOF patients with
exercise stress test results. Correlations between continuous variables were assessed using Pearson’s correlation
coefficient [28]. Probability values < 0.05 were considered
statistically significant.

Results
Demographics

58 rTOF patients, 28 RV dilation patients and 12 normal controls were included (Table 1). rTOF patients
consisted of 47 with TOF-PS (2 DORV variants) and
11 with TOF-PA; 42 had transannular patch repair,
7 had infundibular patch repair, and 9 underwent
RV-PA conduit repair. 11 rTOF patients were statuspost PVR at the time of CMR (Table 2). The mean
PR% was 27.9 ± 16.4%, with 20 patients having severe
PR, 18 with moderate PR and 20 with mild PR. RV

Table 1 Overall demographics
rTOF patients (n = 58)

RV dilation patients
(n = 28)

p

< 0.001

Normal controls (n = 12)

p

13.9 (9.1–17.7)

0.038

Demographics
Age (years), IQR

21.7 (12.2–29.6)

11.5 (4.0–15.5)

Female

30 (51%)

14 (50%)

BSA (m2)

1.5 ± 0.40

1.2 ± 0.6

TOF-PS 47 (84%)
TOF-PA 11 (16%)

PAPVR 24 (85%)
2° ASD 4 (15%)

203 ± 81
65 ± 21

Native anatomy

6 (50%)
< 0.001

1.4 ± 0.5

ns

165 ± 110

ns

131 ± 55

0.0017

61 ± 29

ns

38 ± 10

< 0.001

0.0 ± 0.04%

< 0.001

CMR data
RVEDV (mL)
RVEDVI (mL/m2)
RVESVI (mL/m2)
RVEF (%)
PR%
Qp:Qs

131 ± 33

51.1% ± 5.5%

27.9% ± 16.4%

1.0 ± 0.05

148 ± 57

60.4% ± 6.1%

2.5 ± 1.4

ns
< 0.001
< 0.001

86 ± 15

60.0% ± 5.8%

0.0 ± 0.03%

1.0 ± 0.08

< 0.001
< 0.001
< 0.001
ns

Fifty-eight repaired tetralogy of Fallot (rTOF) patients, 28 patients with right ventricular (RV) dilation and twelve normal controls were included. RV dilation patients
had either partial anomalous pulmonary venous return (PAPVR) or large secundum type atrial septal defects (2° ASD). There was selection bias in that rTOF patients
tended to be older and larger than RV dilation patients, although had similar indexed right ventricular end-diastolic volume index (RVEDVI) and RV end-systolic
volume index (RVESVI)
BSA body surface area, RVEF right ventricular ejection fraction, PR% pulmonary regurgitation percent
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Table 2 Demographics of repaired tetralogy of Fallot (rTOF) cohort

Age of complete repair (years), IQR

TOF-PS (n = 47)

TOF-PA (n = 11)

1.4 (0.3–1.9)

1.2 (0.2–1.7)

Type of surgery
Initial Blalock-Taussig-Thomas shunt palliation

8 (17%)

3 (27%)

Transannular patch

39 (83%)

3 (27%)

Infundibular patch

7 (15%)

0 (0%)

Right ventricle-to-pulmonary artery conduit

1 (2%)

8 (72%)

Subsequent pulmonary valve replacement

8 by surgery (17%)

2 by surgery, 1 by
catheterization
(27%)

The cohort consisted of patients with either tetralogy of Fallot-Pulmonary Stenosis (TOF-PS) or tetralogy of Fallot-Pulmonary Atresia (TOF-PA). 10 patients already had
pulmonary valve replacement

dilation patients consisted of 24 with PAPVR, and 4
with secundum type ASD. Within PAPVR patients, 17
had right-sided PAPVR and associated atrial communication (15 with superior sinus venosus defect, 2 with
inferior sinus venosus defect), and the remaining 7 had
isolated left-sided PAPVR. There was selection bias in
that rTOF patients were older and larger compared to
RV dilation and control patients, although both rTOF
and RV dilation patients had similar enlarged RVEDV
and RVEDVI (203 ± 81 mL and 131 ± 33 mL/m2 vs
165 ± 110 mL and 147 ± 58 mL/m2, p = ns).
Comparison of vorticity between rTOF, RV dilation
and control

Overall quantification results of vorticity are shown
in Fig. 3A, B. Between rTOF, RV dilation and control groups, there were no significant differences in
regional systolic vorticity (p = ns). Meanwhile, ωRVOTDiastole, ωRV Inflow-Diastole, RVOT-VQ and RV-DVQ
were different across groups (p < 0.001). ωRVOT-Diastole
and RVOT-VQ were highest in rTOF with severe
PR (96.5 ± 15.6/s, 1.05 ± 0.26) compared to rTOF
with moderate PR (75.3 ± 15.3/s, 0.73 ± 0.21), rTOF
with mild PR (57.6 ± 15.9/s, 0.70 ± 0.20), RV dilation (64.7 ± 21.5/s, 0.75 ± 0.28) and normal controls
(50.2 ± 16.9/s, 0.56 ± 0.18). ωInflow-Diastole was highest in
RV dilation patients (77.9 ± 25.3/s), compared to rTOF
patient with severe PR (52.7 ± 13.6/s), rTOF patients
with moderate PR (54.5 ± 12.0/s), rTOF with mild PR
(50.4 ± 8.6/s), and control group (58.9 ± 17.8/s). RVDVQ was highest in rTOF with severe PR (1.88 ± 0.33),
compared to rTOF with moderate PR (1.43 ± 0.34) and
rTOF with mild PR (1.17 ± 0.43); whereas RV-DVQ is
normalized in RV dilation patients (0.85 ± 0.18) and
similar to normal controls (0.87 ± 0.26).

Comparison of RVOT energy loss between rTOF, RV dilation
and control

VEL measurements across the RVOT are demonstrated in Fig. 3C. There were no significant differences in V
 ELRVOT-Systole between rTOF, RV dilation and
control groups (p = ns). Meanwhile, there were differences in 
VELRVOT-Diastole and RVOT-EQ (p < 0.001).
VELRVOT-Diastole and RVOT-EQ was highest in rTOF with
severe PR (2.53 ± 1.51 mW, 1.24 ± 0.65) compared to
rTOF with moderate PR (1.18 ± 1.03 mW, 0.56 ± 0.31),
rTOF with mild PR (1.27 ± 1.31 mW, 0.55 ± 0.24), RV
dilation patients (1.12 ± 1.16 mW, 0.75 ± 0.28) and normal controls (0.50 ± 0.58 mW, 0.56 ± 0.18).
Qualitative comparison of intracardiac flow

The representative differences in flow topology between
each cohort are demonstrated by velocity vector fields
(Fig. 4), particle tracking (Fig. 5A) and vorticity mapping (Fig. 5B). During systole, the particle tracking profile
appeared similar between groups. In diastole for both RV
dilation and control cases, an organized, “donut”-shaped
ring-vortex was visualized surrounding the tricuspid
inflow. The superior edge of the diastolic vortex propagated in a counterclockwise pattern directly towards the
RVOT. In comparison, the rTOF cohort in diastole demonstrated dominant vorticity formation starting in the
RVOT from PR, limiting the ring-vortex profile from tricuspid valve.
Subgroup analysis of TOF‑PS patients and only primary
repair

Among the rTOF cohort, there were 36 patients who had
TOF-PS status-post infundibular or transannular patch
repair with no further surgical reintervention. Within this
subgroup, there were fair-to-high correlations between
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Fig. 3 Vorticity and power loss results. When compared to right ventricular dilation (RVD) and control groups, repaired tetralogy of Fallot (rTOF)
patients with severe pulmonary regurgitation (PR% > 40%) had the highest diastolic vorticity in the right ventricular outflow tract (RVOT), as shown
in A. This group also had the highest diastolic vorticity quotient (RV-DVQ) and right ventricular outflow tract vorticity quotient (RVOT-VQ) as shown
in B; as well as the highest  RVOT viscous energy loss (VEL) as shown in C

intracardiac flow parameters with RVEDVI, RVESVI,
RVEF and PR% (Table 3, Fig. 5A–C). RV-DVQ correlated
with RVEF (− 0.521, p = 0.001), PR% (0.774, p < 0.001),

RVEDVI (0.683, p < 0.001), RVESVI (0.696, p < 0.001) and
QRS duration (0.402, p = 0.017). RTOF-EQ correlated
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Fig. 4 Qualitative intracardiac flow profile via velocity vector fields overlaid onto cine imaging. Blue arrows are pointed to larger vorticity
magnitude, red arrows pointed to smaller vorticity magnitude. In rTOF patients, there is a dominant vortex generated from pulmonary insufficiency,
best visualized in short axis (SAx) and modified right ventricular outflow tract (RVOT) view. This vortex is separate from the smaller vortices
generated by the tricuspid inflow, best visualized in the 4-chamber (4Ch) view. For right ventricular dilation (RVD patients), a larger vortex is
generated from tricuspid inflow and propagates into the RVOT, but the overall flow topology is unchanged when compared to controls

with RVEF (− 0.472, p = 0.0032), PR% (0.584, p < 0.001),
RVEDVI (0.415, p = 0.011), RVESVI (0.461, p = 0.004).
Subgroup analysis of rTOF patients with exercise stress test

Among the rTOF cohort, 19 patients had exercise stress
test performed within 2.1 ± 5.4 months of CMR study.
This subgroup cohort consisted of 16 with TOF-PS
and 3 with TOF-PA; 17 had transannular patch, 2 had
conduit repair. 7 patients already had PVR. The mean
PR% was 30 ± 16%. The mean V
 O2-max and % predicted
VO2-max was 27.4 ± 7.72 mL/kg/min and 73.6 ± 23.5%
respectively. There were no significant correlations between VO2-max and % predicted VO2-max with

conventional CMR measurements of the RV. Meanwhile, exercise stress test results moderately correlated
with 4D flow parameters (Table 4, Fig. 6D). RVOTVQ and RVOT-EQ negatively correlated with VO2-max
(− 0.587, p = 0.008; -0.617, p = 0.005) and % predicted
VO2-max (− 0.678, p = 0.0014; − 0.690, p = 0.001).

Discussion
This study retrospectively analyzed 4D flow datasets
to quantify regional vorticity and energy loss in rTOF
patients, compared to normal normal controls and RV
dilation patients. The main findings of this study include:
(1) increased RVOT vorticity and energy loss in diastole
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Fig. 5 Qualitative intracardiac flow profile via particle tracking (A, B) vorticity mapping. A Particles were color-coded based on original position in
end-diastole. Red particles start from tricuspid inflow, green particles from right ventricular outflow tract (RVOT), and blue from remaining body/
apex. An organized, “donut”-shaped ring-vortex was visualized surrounding the tricuspid inflow in right ventricular dilation (RVD) and control
cases, whereas this profile is disrupted in repaired tetralogy of Fallot (rTOF) patients. B Volumetric representation of vorticity also demonstrates
the ring-vortex as shown. The calculation of RV Diastolic Vorticity Quotient (RV-DVQ) in RTOF patients demonstrates the influence of vorticity from
RVOT; whereas in RVD and control cases, vorticity from RV inflow remains dominant

in rTOF patients, whereas diastolic vorticity in RV inflow
remained dominant in normal controls and RV dilation
patients; (2) correlation of RVOT vorticity and energy
loss with RV dysfunction in TOF-PS patients; and (3)

correlation of RVOT vorticity and energy loss with exercise intolerance.
Conventional CMR measurements inform the timing
of PVR, albeit with limitations. The timing of PVR should
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Table 3 Subgroup correlation analysis of repaired tetralogy of Fallot (rTOF) patients who had infundibular or transannular patch repair
(i.e. no conduit placement) and no pulmonary valve replacement (n = 36)
RVEF %

p

PR %

p

RVEDVI

p

RVESVI

p

QRS

P

Conventional
RVEF (%)
PR%
RVEDVI (mL/m2)
RVESVI (mL/m2)
QRS (ms)
Vorticity
ωRVOT-Diastole
RTOF-VQ (ωRVOT-Diastole/ωRVOT-Systole)
RV-DVQ (ωRVOT-Diastole/ωRV Inflow-Diastole)
Energy loss
 VELRVOT-Diastole
RTOF-EQ ( VELRVOT-Diastole/VELRVOT-Systole)

− 0.460

− 0.453

0.005

− 0.460

0.0048 − 0.453
0.702

0.005 − 0.685

< 0.001

0.695

0.015

< 0.001

0.408

0.017

< 0.001

0.421

0.012

0.449

0.007

ns

0.005

0.702

< 0.001

− 0.685

< 0.001

0.695

< 0.001

− 0.4075

0.015

0.4076

− 0.327

0.048

0.794

< 0.001

0.637

< 0.001

0.599

< 0.001

0.247

0.002

0.7390

< 0.001

0.635

< 0.001

0.644

< 0.001

0.313

ns

− 0.521

0.001

0.774

< 0.001

0.683

< 0.001

0.696

< 0.001

0.402

0.017

− 0.373

0.023

0.607

< 0.001

0.747

< 0.001

0.721

< 0.001

0.392

0.020

0.003

0.584

< 0.001

0.415

0.011

0.461

0.004

0.201

ns

− 0.496

− 0.472

0.017

0.956

< 0.001 − 0.408

0.956
0.4211

< 0.001
0.012

0.4498

0.007

Table 4 Subgroup correlation analysis of repaired retralogy of Fallot (rTOF) patients with exercise stress test results (n = 19)
VO2-max

p

% Predicted VO2-max

p

Conventional
RVEF (%)
PR%
RVEDVI (mL/m2)
RVESVI (mL/m2)
QRS (ms)
Vorticity
ωRVOT-Diastole
RVOT-VQ (ωRVOT-Diastole/ωRVOT-Systole)
RV-DVQ (ωRVOT-Diastole/ωRV Inflow-Diastole)
Energy Loss
 VELRVOT-Diastole
RVOT-EQ ( VELRVOT-Diastole/VELRVOT-Systole)

ns

0.259

ns

− 0.192

− 0.291

ns

ns

0.252

ns

− 0.267

0.313

ns

− 0.235

− 0.046

ns

ns

− 0.069

ns

− 0.434

ns

− 0.5497

0.016

− 0.266

Ns

− 0.641

0.003

− 0.497

0.03

− 0.375

ns

− 0.587

− 0.617

be optimized to prevent long-term, irreversible consequences of RV dysfunction such as ventricular arrhythmias, exercise intolerance and overt systolic dysfunction
[6, 29–31]. To date the International Multicenter TOF
Registry (INDICATOR), a multi-center international
cohort study, provides the best interpretation of RV dysfunction in rTOF patients by CMR, identifying RVEF as
a significant risk factor for death and ventricular tachycardia [32]. However, it is also clear that conventional
metrics of PR% and ventricular size/function cannot predict deterioration of the RV [4]. It has also been shown
by meta-analysis that for large RVs, improvements in RV
size after PVR do not necessarily improve RVEF and is
less correlated to improvement of symptoms [33]. Electromechanical dyssynchrony and scar burden appear to
be more associated with exercise intolerance and RVEF
compared to PR% [10, 34]. The CMR metrics do not fully

0.008

0.005

− 0.166

− 0.678

− 0.6902

ns

0.001

0.001

capture the underlying pathophysiology of RV dysfunction in rTOF patients. Thus, PR and RVEDVI are only
fairly correlated with RVEF and not correlated with exercise capacity. Meanwhile, the proposed 4D flow parameters have correlations with RVEF, RF%, RVEDVI, and
exercise capacity.
The 4D flow parameters and analysis of diastolic vortical flow patterns show that RV dilation patients still have
preserved diastolic filling, despite having larger RV size.
In control and RV dilation cases, the observed “donut”
of diastolic vortex from tricuspid inflow is consistent
with our previous in-vitro investigations [18–20], computational studies derived from 3D echocardiography
[35–37] and in-vivo observations of 4D flow [38]. Early
work by Pasipoularides et al. demonstrated the role of the
diastolic vortex in reducing the “convective deceleration
load” and improve ventricular filling [36]. Specifically,
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Fig. 6 Correlations of vorticity and energy loss to conventional indices in subgroup analysis. A–C are from subgroup analysis of repaired tetralogy
of Fallot (rTOF) patients with previous anatomy of Tetralogy of Fallot, Pulmonary stenosis (TOF-PS) and only infundibular or transannular patch
repair (i.e. no conduit placement) and no further surgical reintervention (i.e. no pulmonary valve replacement). D is from subgroup analysis of RTOF
patients with exercise stress test

the “donut” vortex is likely generated by the longitudinal
motion of the RV during diastole, with no active acceleration/deceleration components that would exert additional hemodynamic forces in the RV. The propagation of
the inflow vortex towards the RVOT may also facilitate
systolic flow [39]. RV-DVQ takes into account the relative
impact of the inflow vortex towards the RVOT; thus as a
normalized parameter, RV-DVQ is not significantly different between RV dilation and normal controls (Fig. 4B).
In our study, specific regional measurement by 4D
flow was key to highlighting the complex interplay
between PR and RV size/function in rTOF patients.
In-vivo and in-vitro studies of aortic regurgitation in
the left ventricle show that when the inflow vortex is
interrupted by a colliding jet of insufficiency, there
is increased vortical flow formation and energy loss
[40–42]. rTOF patients in similar fashion have higher
vorticity and energy loss from PR in the RVOT, as the
local jet collision creates a distinct intracardiac topology which generates shear layers, small-scale turbulence or turbulent-like flow [16, 18–20]. This effect is
determined by PR, inflow, RV geometry (e.g. the relative angle of inflow and PR), which may explain why

RVOT vorticity and energy loss correlate with RV size,
RV function and PI in RTOF. Considering that RV
function and exercise capacity tend to be preserved in
rTOF with transatrial-transpulmonary approach, or
in patients with isolated PS status post valvotomy (i.e.
minimized or absent ventriculotomy in RVOT) [43, 44],
the RVOT may also function to attenuate the abnormal
flow features from PR.
Furthermore, the native diastolic vortex from tricuspid
inflow is dominated by RVOT vorticity, leading to higher
RV-DVQ (Fig. 4B). RV-DVQ was also correlated with
longer QRS duration (i.e. right bundle branch block).
Electromechanical dyssynchrony likely affected RV longitudinal wall motion [10], which in turn weakens the
tricuspid inflow vortex. The competing nature between
PI and tricuspid inflow is also observed in in-vitro studies [16, 18], and may lead to abnormal hemodynamic
forces in directed from the RVOT towards the RV base,
as demonstrated by Sjoberg et al. [45]. The vortex interaction and resultant hemodynamic forces likely contributes to altered mechanotransductive environment that
leads to RV dysfunction [46, 47]. The abnormal hemodynamic forces may also contribute to the abnormal RVOT
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shape geometry found in larger RVs [7]. PVR would likely
restore the natural diastolic vortex and help restore RV
function; thus RVOT vorticity and energy loss could
potentially be biomarkers to guide PVR therapy.
The subgroup correlation results of RV-DVQ, RVOTVQ and RVOT-EQ suggest that the 4D flow measurements, by capturing PR as localized intracardiac
phenomena, reflects the clinical range of RV dilation
and dysfunction created in rTOF patients. Shibata et al.
using vector flow mapping by echocardiography, demonstrated that diastolic energy losses correlated with
RV deterioration [48]. Measurements of kinetic energy
have also demonstrated global RV abnormalities with
varying correlations to RV size and RV function [15,
49]. Frediksson et al. in particular measured turbulent
kinetic energy [14] derived from the magnitude imaging of individual flow-encoding segments rather than
the velocity field. In that study, rTOF patients with
larger RVEDVI had higher turbulent kinetic energy.
These abnormalities are likely sources of energy loss
that contributes to RV pump inefficiency in rTOF
patients [48, 50].
Furthermore, the interaction between PR and tricuspid inflow potentially limits augmentation of RV cardiac
output during exercise, leading to exercise intolerance.
Previous CMR studies have not demonstrated any significant correlation between RV size and PR with exercise capacity [8, 9, 11], informing the use of modified
parameters such as ventricular global function index [9].
Thus far, only right ventricular systolic dysfunction and
branch pulmonary artery size discrepancy have correlated with decreased exercise capacity [7, 11, 51]. In our
subgroup cohort, RVOT-VQ and RVOT-EQ correlated
with VO2-max and % predicted V
 O2-max, suggesting that
the abnormal intracardiac flow patterns from PR is still
the link to exercise intolerance in rTOF patients. Ideally, these 4D flow parameters would be investigated
with exercise CMR [52], although the decreased signalto-noise ratio and motion artifact during exercise would
likely limit interpretation of such findings. We aim to
develop these as novel imaging biomarkers linking the
pathophysiology between PR and exercise intolerance, to
ultimately assist in the decision of optimal timing of PVR.
In addition to intracardiac flow, there are other potential biomarkers of RV size/function beyond volumetric
measurements. Studies investigating myocardial strain
by feature tracking have demonstrated impairments in
RV global strain and ventricular dyssynchrony in rTOF
patients [30, 53]. RV scar burden as defined by late gadolinium enhancement volume also correlates with ventricular dysfunction and risk of inducible ventricular
arrhythmias [34]. Shape modeling studies have demonstrated morphological changes beyond measurements
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of RVEDVI and RVESVI [5, 7, 54]. Computational load
analysis of the RV myocardium, including the akinetic
RVOT free wall [55] may also be sensitive in predicting
RV dysfunction.
Prior studies

Compared to other 4D CMR studies on rTOF, our study
has the benefit of (1) a larger sample size, with comparison against normal controls as well as RVD representing
other chronic volume loading states and (2) a specific
regional focus of 4D flow biomarkers to avoid dilution of
results by including tricuspid inflow. For example, Hirtler
et al. investigated 24 rTOF patients and measured higher
mean RV vorticity, but these measurements were paradoxically negatively correlated with RV size [12]. This
finding likely resulted from measurements derived in the
4-chamber cine plane, which only isolates the tricuspid
inflow vortex (whereas our data would suggest that this
component is weakened by PR).
Study limitations

The study, while larger than other 4D flow studies of
rTOF, is still a single-center analysis and limited by sample size. The rTOF cohort was heterogenous in both
anatomy and surgical repair, limiting the correlations
observed in the study (although subgroup analysis of
TOF-PS patients still had consistent results). As a retrospective study, the clinical 4D flow datasets did not
include dedicated magnitude imaging which is required
to calculate other 4D flow-based parameters such as
turbulent kinetic energy. Late gadolinium enhancement
was also not routinely performed in this study, which
precluded the investigation of peri-patch fibrosis in the
RVOT [34] and its effect on intracardiac flow. For 4D flow
analysis, we intentionally cut arbitrary, static planes in RV
end-diastolic models to minimize inter-observer variability inherent with mask segmentation of RV regions. This
potentially limited analysis of the RVOT during systolic
movement, although this effect may be minimal as rTOF
cases tend to have akinetic RVOT. There was inconsistent
timing of exercise stress test in rTOF patients, although
the time interval between CMR and stress tests were still
within recommended surveillance guidelines of rTOF
patients [2] and is unlikely to significantly alter results
based on previous longitudinal studies [56, 57]. Most
importantly, the limited spatial and temporal resolution
of 4D flow prohibited detailed assessment of smaller vortical interactions formed by the collision of PR into the
tricuspid vortex and the propagation of turbulent flow
into the RV body and myocardium, particularly the trabeculations [58]. Thus, we did not assess hemodynamic
parameters such as wall shear stress along the RV free
wall, which likely has an influence on RV dilation.
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Future studies

Future work will focus on in-depth flow quantification
in rTOF patients, to further elaborate on the influence
of vorticity/energy loss towards RV dysfunction and
exercise intolerance. These will include refining computational models of RV intracardiac flow in rTOF patients
[18–20] and using advanced echocardiography techniques such as vector flow mapping [48] or blood speckle
imaging [59]. These methods could potentially overcome
the spatial and temporal limitations of 4D flow, further
refining flow biomarkers to account for other factors
such as heart rate, voxel size or presence of late gadolinium enhancement. As the variable RVOT geometry in
rTOF patients [7] may also alter the angle of jet collision
between PI and tricuspid inflow, we will also investigate
this relationship with statistical shape modeling. We plan
to prospectively use 4D flow and computational modelling to investigate intracardiac flow in RTOF patients
before-and-after PVR, as well as during exercise. We aim
to further develop vorticity and energy loss as clinical
biomarkers to aid in timing of PVR for rTOF patients.

Conclusion
In rTOF patients, abnormal vorticity and energy loss
dominate the RVOT compared to tricuspid inflow. These
4D flow-based parameters are potential biomarkers that
are distinct from other forms of chronic RV volume
loading, representing abnormal intracardiac flow that
contribute to RV dysfunction and exercise intolerance.
Future studies should investigate the role of intracardiac
4D flow in guiding PVR therapy.
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